Johnson & Johnson (JNJ)
(Real Time Quote from BATS)
$149.14 USD
+0.56 (0.38%)
Updated May 7, 2024 09:48 AM ET
3-Hold of 5 3
B Value C Growth B Momentum C VGM
Brokerage Reports
Johnson & Johnson [JNJ]
Reports for Purchase
Showing records 1 - 20 ( 498 total )
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Menin Inhibitors Carving Out a Niche in Leukemias: Rationale, Opportunities, and Candidates
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 21124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 12124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 1124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 12123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended November 24.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 112123
Provider: Stock Traders Daily
Analyst: Research Department